Am J Gastroenterol

1. GERBER A, Yoon JY, Hur C, Rubenstein JH, et al
   Greater Esophageal Cancer Burdens in Rural United States: A Surveillance, Epidemiology, and End Results Program Analysis.
   Am J Gastroenterol. 2026 Aug 28. doi: 10.14309/ajg.0000000000004189.
   

   >> Share

   
   

   
   Ann Otol Rhinol Laryngol

2. ROURK KS, Hidalgo CM, Shurtz AK, Tasche KK, et al
   Long-Term Survey to Assess Recurrence and Complications of Surgically Treated Pleomorphic Adenoma.
   Ann Otol Rhinol Laryngol. 2026;135:780-788.
   

   >> Share

   
   

   
   Anticancer Res

3. TODA S, Kasajima R, Okubo Y, Saito N, et al
   Utility of RNA Sequencing and Immunohistochemistry for NTRK Fusion in Thyroid Carcinoma.
   Anticancer Res. 2026;46:4923-4933.
   

   >> Share

   
   
4. HAMAI Y, Ibuki Y, Ohsawa M, Kitasaki N, et al
   Comparative Evaluation of Short-term Outcomes Between Initial and Later Periods After Introduction of Robot-assisted Surgery for Esophageal Cancer.
   Anticancer Res. 2026;46:5259-5269.
   

   >> Share

   
   
5. KANG KR, Kim DK, Lim H, Chun HS, et al
   Icariin Induces Autophagy-dependent Apoptosis in FaDu Head and Neck Squamous Cell Carcinoma.
   Anticancer Res. 2026;46:4935-4948.
   

   >> Share

   
   
6. JIAO W, Wang D, Han J, Liu Y, et al
   Integrated Spatial Immune Phenotyping Identifies a Suppressive-infiltrated High-risk Subgroup in Esophageal Squamous Cell Carcinoma.
   Anticancer Res. 2026;46:5095-5118.
   

   >> Share

   
   

   
   Br J Cancer

7. YUAN J, Gong J, Peng Z, Liu TS, et al
   Efficacy and safety of infigratinib in patients with refractory advanced gastric or gastroesophageal junction adenocarcinoma harboring FGFR2 gene amplification: a single-arm, multicenter phase 2 trial.
   Br J Cancer. 2026;135:924-930.
   

   >> Share

   
   
8. KONO T, Kasahara K, Ogawa R, Ozawa H, et al
   Radiomics as a spatial context for treatment decision-making in head and neck cancer.
   Br J Cancer. 2026 Sep 3. doi: 10.1038/s41416-026-03600.
   

   >> Share

   
   

   
   Clin Cancer Res

9. JOVE M, Brana I, Oliva M, Hernando-Calvo A, et al
   Phase I Trial of Intravenous VCN-01 Oncolytic Adenovirus and Durvalumab in Patients with Head and Neck Metastatic Squamous Cell Carcinoma Refractory to Immunotherapy.
   Clin Cancer Res. 2026;32:3786-3798.
   

   >> Share

   
   
10. KAVANAGH FG, Instrum RS, Boe LA, Eagan AJ, et al
    Nonoperative Management of Locally Advanced Resectable Cutaneous Squamous Cell Cancer of the Head and Neck with PD-1 Blockade.
    Clin Cancer Res. 2026;32:3911-3920.
    

    >> Share

    
    

    
    Dis Esophagus

11. ABE T, Higaki E, Hosoi T, Inada K, et al
    Oncological outcomes and recurrence patterns after robot-assisted versus video-assisted esophagectomy for cT3br/cT4b esophageal cancer.
    Dis Esophagus. 2026;39:doag095.
    

    >> Share

    
    

    
    Head Neck

12. COOKE PV, Kraft DO, Chennareddy S, Sicard R, et al
    The Utility of Tumor Tissue-Modified Viral HPV DNA Testing for HPV-Associated Non-Oropharyngeal Squamous Cell Carcinoma of the Head and Neck.
    Head Neck. 2026 Sep 1. doi: 10.1002/hed.70448.
    

    >> Share

    
    

    
    Int J Cancer

13. DUYMAZ MC, Ozkaya Duymaz E, Unsal N, Bekis R, et al
    Pretreatment EBV-DNA/TLG-Based Risk Stratification Is Associated With Survival Outcomes in Nonmetastatic Nasopharyngeal Carcinoma: An Exploratory Study.
    Int J Cancer. 2026 Sep 1. doi: 10.1002/ijc.70732.
    

    >> Share

    
    

    
    Int J Radiat Oncol Biol Phys

14. MCBRIDE SM, Bakst RL, Schoenfeld JD, Ng SP, et al
    Shifting the Curve in Head and Neck Cancer: More Treatment, Less Treatment, or Better Treatment?
    Int J Radiat Oncol Biol Phys. 2026;126:283-288.
    

    >> Share

    
    
15. WANG D, Lee SH, Wang T, Xiao Y, et al
    Assessment of Defacing Techniques on Medical Images for Radiation Therapy: Implications for Patient Privacy and Data Utility.
    Int J Radiat Oncol Biol Phys. 2026;126:502-519.
    

    >> Share

    
    
16. MA L, Tayier N, Hu W, Chen J, et al
    Alternative End Joining Dependency Imposed by miR-21-5p Defines Radiation Resistance and a Targetable Vulnerability in Oral Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2026;126:471-485.
    

    >> Share

    
    
17. MILLER DG, Yacoub I, Aliotta E, Kallini D, et al
    Dosimetric Results for Organs at Risk From Radiation Therapy Dose De-Escalation to the Subclinical Region in Human Papillomavirus-Associated Oropharyngeal Cancer: A Propensity Score-Matched Analysis.
    Int J Radiat Oncol Biol Phys. 2026;126:340-346.
    

    >> Share

    
    
18. CASES C, Latorre-Musoll A, Candela-Juan C, Valduvieco I, et al
    One Year After a Cyberattack: Lessons Learned and Dosimetric Analysis of Contingency Radiotherapy Plans.
    Int J Radiat Oncol Biol Phys. 2026;126:308-317.
    

    >> Share

    
    
19. BRENNAN MT, Passineau MJ, Saunders D, Sroussi H, et al
    Results of a Phase 1 Open-Label, Dose-Escalation Study of Gene Therapy With AAV2-hAQP1 for Grade 2 and 3 Radiation-Induced Late Xerostomia and Parotid Gland Hypofunction.
    Int J Radiat Oncol Biol Phys. 2026;126:330-339.
    

    >> Share

    
    

    
    J Oral Maxillofac Surg

20. LU LS, Liu KY, Jiang TC, Zou JY, et al
    Effect of Biopsy on MRI Accuracy in Preoperative Assessment of Tongue Squamous Cell Carcinoma.
    J Oral Maxillofac Surg. 2026;84:1503-1515.
    

    >> Share

    
    

    
    Laryngoscope

21. URALOV D, Iovine C, Di Cristina L, Paderno A, et al
    Beyond TNM: Tumor Volume as a Prognostic Marker in Laryngeal Cancer.
    Laryngoscope. 2026 Aug 30. doi: 10.1002/lary.70879.
    

    >> Share

    
    
22. LI L, Zhang X, Ren J, Zhao P, et al
    Two-Stage Tracheal Repair for Well-Differentiated Thyroid Carcinoma With Tracheal Invasion.
    Laryngoscope. 2026 Sep 3. doi: 10.1002/lary.70875.
    

    >> Share

    
    

    
    Oral Oncol

23. OKUYAMA K, Yanamoto S
    Integrating minimal residual disease into postoperative treatment selection for head and neck cancer.
    Oral Oncol. 2026;182:108121.
    

    >> Share

    
    
24. GARCIA C, Leao I, Pinto D, Rato ND, et al
    Exercise prehabilitation in head and neck cancer patients proposed for definitive chemoradiotherapy: The FIT4TREAT randomized controlled trial.
    Oral Oncol. 2026;181:108119.
    

    >> Share

    
    
25. HONG MH, Lee S, Kim CG, Son W, et al
    Corrigendum to "A phase II clinical trial of paclitaxel-carboplatin as neoadjuvant therapy followed by surgery in patients with locally advanced head and neck squamous cell carcinoma" [Oral Oncol. 170 (2025) 107745].
    Oral Oncol. 2026 Sep 4:108114. doi: 10.1016/j.oraloncology.2026.108114.
    

    >> Share

    
    

    
    Otolaryngol Head Neck Surg

26. HERNANDEZ-HERRERA GA, Rourk KS, Peraza LR, Moore EJ, et al
    Clinical Features, Treatment, and Outcomes for Oropharyngeal Adenoid Cystic Carcinoma: A Systematic Review.
    Otolaryngol Head Neck Surg. 2026;175:547-555.
    

    >> Share

    
    
27. LOHEIDE SE, Lee BM, Taufique ZM, Moses LE, et al
    Assessing HPV Vaccination Trends and Their Alignment with Evolving Recommendations.
    Otolaryngol Head Neck Surg. 2026;175:622-631.
    

    >> Share

    
    
28. BUHLER LEC, Prince A, Bunda N, Oslin K, et al
    Comparative Outcomes of Fine Needle Aspiration and Core Needle Biopsy for Parotid Masses.
    Otolaryngol Head Neck Surg. 2026;175:632-640.
    

    >> Share

    
    
29. HARRIS MK, Daniels K, Helou V, Carlson K, et al
    Preoperative Neutrophil-to-Lymphocyte Ratio Predicts Recurrence in HPV-Associated Oropharyngeal Cancer After Transoral Robotic Surgery.
    Otolaryngol Head Neck Surg. 2026;175:650-656.
    

    >> Share

    
    
30. BARRETT TF, Jama M, Alshalalfa M, Tharakan T, et al
    Development of Novel mRNA Classifiers to Stratify Preoperative Thyroid Tumor Risk.
    Otolaryngol Head Neck Surg. 2026;175:578-586.
    

    >> Share

    
    

    
    PLoS One

31. MOU L, Zhang T, Zhang X, Zhou J, et al
    68Ga-FAPI-04 PET/CT has high diagnostic efficacy in Tg-positive and Tg-negative differentiated thyroid cancer.
    PLoS One. 2026;21:e0355343.
    

    >> Share

    
    

    
    Radiol Imaging Cancer

32. WU Y, Lin K, Lin N, Lin Y, et al
    Spectral CT-based Nomogram for Noninvasive Assessment and Prognostic Prediction of MSI/dMMR in Esophagogastric Junction Adenocarcinoma.
    Radiol Imaging Cancer. 2026;8:e250654.
    

    >> Share

    
    

    
    Radiother Oncol

33. RUHLE A, Sanz-Garcia E, Su J, O'Sullivan B, et al
    Metastatic patterns, outcomes, and prognostic factors in de novo metastatic head and neck cancer by tumor HPV status.
    Radiother Oncol. 2026 Sep 4:111769. doi: 10.1016/j.radonc.2026.111769.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share